Figure 2B. Genetic Variants Associated with Hypertrophic Cardiomyopathy

Genetic testing has greatly improved physicians’ ability to detect potentially lethal heart anomalies among asymptomatic family members of people who suffer cardiac arrest or sudden cardiac death.

Keynote speaker Karen Aiach with department chair and conference organizer Zak Kohane

Why rogue? Rogues break rules when the old rules no longer work. That is what is happening in the world of Precision Medicine.

Jean Fan of cuSTEMized with area schoolchildren

Kids are natural scientists. Kids love to ask questions, look under rocks, take things apart and (sometimes) try to put them back together again.

Minecraft image courtesty Eighth Wonder via YouTube

"First Opinion" piece by DBMI Chair Zak Kohane appears in today's STAT.

pattern

DBMI and the Harvard Office of Technology Development (OTD) have joined forces to launch the Biomedical Informatics Entrepreneurs Salon (BIES), a monthly meeting to promote entrepreneurship at the convergence of biology, medicine, and computing.

placeholder

​The Precision Medicine Initiative (PMI) Cohort Program aims to enroll more than one million U.S. participants, who will donate health data about themselves for precision medicine research.

HCILS Grand Rounds

The first Harvard Clinical Informatics Lecture Series of 2016 is underway, having kicked off in January with Grand Rounds hosted by DBMI Chair Zak Kohane. Dr. Kohane spoke about the intersection of precision medicine with clinical informatics and operations.

PIC-SURE and NHANES logo on BD2K background

The NIH Office of Data Science recently hosted an all-hands grantee meeting for the country's BD2K Centers of Excellence, during which PI Zak Kohane presented year-one highlights for PIC-SURE.

4D Nucleome project logo

Under its new 4D Nucleome Program, the National Institutes of Health (NIH) Common Fund has awarded $12.5 million over five years to the Data Coordination and Integration Center (DCIC) hosted at DBMI.

N-GRID graphic

Researchers from Harvard Medical School and Massachusetts General Hospital have completed the first stage of an important collaboration aimed at understanding the intricate variables of neuropsychiatric d